Medicare Enrolled
Dr. Heather Yeckes-Rodin, M.D.
Hematology & Oncology · Port St. Lucie, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yeckes-Rodin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yeckes-Rodin? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yeckes-Rodin
Dr. Heather Yeckes-Rodin is a hematology & oncology in Port St. Lucie, FL, with 19 years in practice. Based on federal Medicare data, Dr. Yeckes-Rodin performed 141,696 Medicare services across 7,344 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yeckes-Rodin received a total of $22,937 from 77 pharmaceutical and/or device companies across 1124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yeckes-Rodin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 4% volume in FL$ $22,937 industry payments
Medicare Practice Summary
Medicare Utilization ↗141,696
Medicare services
Top 4% in FL for hematology & oncology
7,344
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,458 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 34,800 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 23,400 | $43 | $91 |
| Iron infusion (Feraheme) | 17,340 | $0 | $3 |
| Contrast dye for imaging (iodine-based) | 16,625 | $0 | $1 |
| Filgrastim injection (Nivestym) for white blood cells | 13,860 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 5,940 | $18 | $30 |
| Dexamethasone injection (steroid) | 3,926 | $0 | $1 |
| Injection, docetaxel, 1 mg | 3,552 | $0 | $7 |
| Complete blood count (CBC) with differential | 2,647 | $8 | $30 |
| Comprehensive metabolic blood panel | 2,140 | $10 | $30 |
| Blood draw (venipuncture) | 1,802 | $8 | $15 |
| Office visit, established patient (20-29 min) | 1,665 | $70 | $210 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,530 | $1 | $10 |
| Epoetin alfa injection (Procrit) for anemia | 1,380 | $6 | $20 |
| Epoetin alfa injection (Retacrit) for anemia | 870 | $6 | $24 |
| Carcinoembryonic antigen (cea) protein level | 800 | $18 | $55 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 719 | $20 | $60 |
| Anti-nausea injection (ondansetron/Zofran) | 632 | $0 | $2 |
| Office visit, established patient (30-39 min) | 553 | $94 | $300 |
| Drug injection, under skin or into muscle | 543 | $11 | $40 |
| Administration of chemotherapy into vein, 1 hour or less | 534 | $104 | $330 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 366 | $23 | $85 |
| Injection of additional new drug or substance into vein | 347 | $13 | $55 |
| Hospital follow-up visit, moderate complexity | 340 | $66 | $165 |
| Cyclophosphamide, 100 mg | 290 | $16 | $71 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 272 | $1 | $6 |
| Injection, carboplatin, 50 mg | 271 | $2 | $10 |
| Vitamin B-12 level test | 232 | $15 | $50 |
| Ferritin level test (iron stores) | 227 | $13 | $40 |
| Iron level test | 227 | $6 | $20 |
| Iron binding capacity test | 227 | $9 | $25 |
| Folic acid level test | 217 | $14 | $55 |
| Lactate dehydrogenase (enzyme) level | 205 | $6 | $20 |
| Injection, diphenhydramine hcl, up to 50 mg | 186 | $1 | $4 |
| Infusion into a vein for hydration, each additional hour | 181 | $11 | $40 |
| Injection, magnesium sulfate, per 500 mg | 176 | $1 | $2 |
| Infusion, normal saline solution , 1000 cc | 170 | $2 | $10 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 165 | $56 | $125 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 157 | $52 | $150 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 155 | $403 | $681 |
| Administration of chemotherapy into vein, each additional hour | 152 | $23 | $80 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 142 | $1,180 | $5,700 |
| CT scan of chest, without contrast | 125 | $51 | $359 |
| Ct scan of chest with contrast | 119 | $46 | $700 |
| Infusion into a vein for hydration, 31-60 minutes | 118 | $27 | $125 |
| Administration of additional new drug or substance into vein, 1 hour or less | 116 | $53 | $165 |
| Ct scan of abdomen and pelvis before and after contrast | 114 | $210 | $1,450 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 108 | $17 | $50 |
| Initial hospital admission, high complexity | 106 | $144 | $460 |
| Magnesium level test | 79 | $7 | $20 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 73 | $26 | $85 |
| Irrigation of implanted venous access drug delivery device | 67 | $19 | $55 |
| New patient office visit, complex (60-74 min) | 62 | $173 | $520 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 61 | $4 | $12 |
| Prothrombin time test (blood clotting) | 60 | $4 | $15 |
| Ct scan of abdomen and pelvis without contrast | 53 | $79 | $1,075 |
| Manual urinalysis test with examination using microscope, non-automated | 51 | $4 | $20 |
| Blood creatinine level | 48 | $5 | $15 |
| Urea nitrogen level to assess kidney function, quantitative | 48 | $4 | $7 |
| Basic metabolic blood panel | 47 | $7 | $25 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 45 | $1 | $4 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 44 | $3 | $10 |
| Ct scan of soft tissue of neck with contrast | 40 | $60 | $550 |
| PSA test (prostate cancer screening) | 38 | $18 | $75 |
| Collection of blood sample from implanted device | 36 | $21 | $50 |
| Drawing of blood for a medical problem | 26 | $74 | $165 |
| Stool analysis for blood, by peroxidase activity | 25 | $4 | $10 |
| Ct scan of soft tissue of neck without contrast | 24 | $53 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.0% high complexity
77.6% medium
9.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,937
Total received (2018-2024)
Avg $3,277/year across 7 years
Top 23% in FL for hematology & oncology
77
Companies
1,124
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,897 (82.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,356 (10.3%)
Other
Charitable contributions, space rental, and other categories
$1,190 (5.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$494 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,343
2023$3,431
2022$2,237
2021$2,123
2020$2,402
2019$2,955
2018$4,446
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$3,460
PFIZER INC.
$1,776
AstraZeneca Pharmaceuticals LP
$1,276
Amgen Inc.
$1,086
Lilly USA, LLC
$901
GENZYME CORPORATION
$892
Genentech USA, Inc.
$884
Janssen Biotech, Inc.
$830
GlaxoSmithKline, LLC.
$638
Seagen Inc.
$633
Incyte Corporation
$632
E.R. Squibb & Sons, L.L.C.
$593
Daiichi Sankyo Inc.
$572
Merck Sharp & Dohme Corporation
$569
Regeneron Healthcare Solutions, Inc.
$551
Tempus AI, Inc
$516
Merck Sharp & Dohme LLC
$510
Takeda Pharmaceuticals U.S.A., Inc.
$418
Celgene Corporation
$372
Bayer HealthCare Pharmaceuticals Inc.
$346
Gilead Sciences, Inc.
$345
ASD Specialty Healthcare, LLC
$323
Celltrion USA Inc.
$295
Astellas Pharma US Inc
$279
Puma Biotechnology, Inc.
$264
Kite Pharma, Inc.
$232
PUMA BIOTECHNOLOGY, INC.
$229
Boehringer Ingelheim Pharmaceuticals, Inc.
$200
EISAI INC.
$185
TESARO, Inc.
$182
ABBVIE INC.
$181
BeiGene USA, Inc.
$178
Mirati Therapeutics, Inc.
$172
Coherus Biosciences Inc.
$166
AbbVie Inc.
$160
Karyopharm Therapeutics Inc.
$137
Ipsen Biopharmaceuticals, Inc
$132
Dova Pharmaceuticals
$128
AbbVie, Inc.
$101
Janssen Products, LP
$100
Eisai Inc.
$99
Janssen Pharmaceuticals, Inc
$93
Pharmacyclics LLC, An AbbVie Company
$92
ARRAY BIOPHARMA INC
$92
SOBI, INC
$91
AMAG Pharmaceuticals, Inc.
$90
Exelixis Inc.
$88
JAZZ PHARMACEUTICALS INC.
$79
Alexion Pharmaceuticals, Inc.
$66
Seattle Genetics, Inc.
$58
ACCORD HEALTHCARE, INC.
$45
EMD Serono, Inc.
$41
Taiho Oncology, Inc.
$39
Verastem, Inc.
$38
Sobi, Inc
$33
Otsuka America Pharmaceutical, Inc.
$33
Helsinn Therapeutics (U.S.), Inc.
$29
Jazz Pharmaceuticals Inc.
$29
Aurobindo Pharma USA, Inc.
$27
IntrinsiQ Specialty Solutions, Inc.
$25
Foundation Medicine, Inc.
$24
AVEO Pharmaceuticals, Inc.
$23
Amneal Pharmaceuticals LLC
$22
MEDIVATION FIELD SOLUTIONS LLC
$20
Myovant Sciences Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
Genmab U.S., Inc.
$19
Cardinal Health 108, LLC
$18
MorphoSys, US Inc.
$18
INSYS Therapeutics Inc
$18
Array BioPharma Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
Agios Pharmaceuticals, Inc.
$16
Acceleron Pharma, Inc.
$16
Clovis Oncology, Inc.
$15
Advanced Accelerator Applications
$14
Allergan Inc.
$13
Top 3 companies account for 28.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · Abraxane · Alecensa · Aliqopa · Avastin · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CHANTIX · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LINZESS · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rubraca · SARCLISA · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $16 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
24
Per 100K population
6.9
County median income
$69,027
Nearest hospital
ST LUCIE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Yeckes-Rodin is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Yeckes-Rodin experienced with injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram?
Based on Medicare claims data, Dr. Yeckes-Rodin performed 34,800 injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yeckes-Rodin receive payments from pharmaceutical companies?
Yes. Dr. Yeckes-Rodin received a total of $22,937 from 77 companies across 1,124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yeckes-Rodin's costs compare to other hematology & oncologys in Port St. Lucie?
Dr. Yeckes-Rodin's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yeckes-Rodin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Port St. Lucie
Browse hematology & oncologys in Port St. Lucie ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology